Authors
Latest:
Functional Gastrointestinal DisordersIn 2013, a CDC study reported that gastrointestinal (GI)-related dysfunction was responsible for 13,011 annual outpatient office visits.
Latest:
The New Compounding Law and Community Pharmacy's FutureMeaningful federal compounding legislation has been developed.
Latest:
Is it Time to Take Another Look at Retail at Specialty Pharmacy?The concept of specialty at retail has the potential to unlock vast financial, contracted volume, and patient continuum of care opportunities attached to pharmaceutical products currently dispensed in specialty pharmacies.
Latest:
Rx Product News: Profile: A Closer Look at New FDA Actions: AmitizaThe FDA recently approved Amitiza for the treatment of irritable bowel syndrome with constipation in women aged 18 years and older.
Latest:
The Pharmacist’s Role: Opioid-related Risks With a Psychiatric DrugPharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Latest:
Smart Bottles: Implementation ConsiderationsWhat to consider when considering a smart bottle program.
Latest:
Reactions to Pharmacy Times Health-System EditionStephen F. Eckel, PharmD, MHA, Pharmacy Times Health-System Edition editor discusses the overall reactions he has heard surrounding Pharmacy Times Health-System Edition.
Latest:
The Backup Pharmacist-in-Charge: The Growing Importance to Specialty PharmacyProper succession planning for your pharmacist-in-charge is a must for continuity of business.
Latest:
Revisiting "Right to Try" LegislationIn summer 2016, Pharmacy Times® published an article titled “‘Right to Try’ Legislation: A Developing Legal Issue Related to Medications” that discussed the basics of a popular health policy issue.
Latest:
Travel Immunization in the Pharmacy: Exploring the Growing OpportunityUS citizens are increasingly traveling to international destinations, with Americans making 38 million visits abroad in 2017. Fortunately, pharmacists are well-placed to assist patients in their travel health needs.
Latest:
New FDA Actions: UCB's NeuproThe FDA approved Neupro (Rotigotine Transdermal System) for the treatment of Parkinson's disease and restless leg syndrome.
Latest:
CDC: Many Pre-Pandemic Activities Can Resume for Fully Vaccinated IndividualsThe agency also advised that fully vaccinated individuals can resume many activities without wearing a mask or social distancing.
Latest:
Think Outside the Box for Front-End Profit Opportunities in the PharmacyTaking steps to improve front-end sales takes some time and out-of-the-box thinking, but it can prove profitable and improve word-of-mouth recommendations.
Latest:
A Computerized Asthma Outcomes Measure Is Feasible for Disease ManagementThe ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.
Latest:
Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast CancerCompared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.
Latest:
Hepatitis C Case Study at Prosperity Specialty PharmacyAdherence for targeted therapies is even more essential now than it ever has been. This case study of services offered at a specialty pharmacy illustrates the impact of hepatitis C patients.
Latest:
Daily Dose and Costs of Therapy With Topical Testosterone AgentsWe assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.
Latest:
Assessing the Impact of Patient Assistance Programs on Financial Toxicity in Oral OncologyPAPs can significantly reduce OOP costs for patients.
Latest:
Leukemia: Causes, Symptoms, and TreatmentsLeukemia is a type of cancer that affects blood cell formation and the lymphatic system. It can be classified by cell type, lymphoid or myeloid, and the rate of progression, acute or chronic.
Latest:
New Evidence Concerning Safety of ACE Inhibitors, ARBs in COVID-19There continues to be a debate in the scientific community about the role that angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers play in coronavirus disease 2019 infection.
Latest:
Expert Panel Examines Biosimilar PathwayThe FDA does not usually require animalstudies for biosimilars; therefore, the process can move directly to pharmacokinetic and pharmacodynamic studies.
Latest:
Burden of Autosomal Dominant Polycystic Kidney Disease: Systematic Literature ReviewThe authors present a review of the literature for autosomal dominant polycystic kidney disease to characterize its impact on patients and healthcare systems.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
What Factors Influence Response to Multiple Myeloma Treatment?Two recent studies analyzed factors that impacted response to therapy in patients with multiple myeloma.
Latest:
To Substitute or Not to Substitute: That Is the QuestionWith generic prescriptions on the rise, every pharmacist needs a through understanding of therapeutic equivalence and the generic approval process.
